Company Overview
Cardlytics, Inc. operates a proprietary advertising platform that enables marketers to reach customers through various digital channels, including online spaces, mobile applications, email, and video, within the United States and the United Kingdom. The company functions within the Communication Services sector as part of the Advertising Agencies industry, positioning itself as a specialized intermediary between financial institutions and digital ad spend. This entity employs a workforce of 275 individuals to manage its technical infrastructure and client relationships across its primary operational markets. With a market capitalization of $51.33M and trailing twelve-month revenue of $233.27M, the company presents a relatively small-scale capitalization relative to its reported revenue stream. These valuation metrics indicate that the market assigns a low premium to the company's earnings potential, suggesting that investors view the firm as a micro-cap asset with significant leverage to its revenue base but constrained by its current profitability status.
Financial Health
The company reported total revenue of $233.27M over the trailing twelve months, yet this generated a net income loss of $103,488,000 and an EBITDA of $-21,897,000. The substantial gap between the positive revenue figure and the negative net income reveals a cost structure where expenses, likely driven by sales, general, and administrative costs, significantly outpace the gross profit generated from advertising sales. Despite the net loss, the company maintains a positive free cash flow of $4.72M, which indicates that it generates sufficient cash from operations to cover its capital expenditures and working capital needs, thereby preserving some financial flexibility for liquidity management. The company's profitability is further contextualized by three distinct margin figures: a gross margin of 44.8%, an operating margin of -9.9%, and a profit margin of -44.4%. The positive gross margin suggests that the core advertising product retains a healthy markup, while the negative operating and profit margins highlight that overhead costs and other operating expenses are consuming nearly half of the revenue before reaching the bottom line. On the balance sheet, the company holds $48.72M in cash against $215.31M in debt, creating a situation where liabilities exceed liquid assets, and the debt-to-equity ratio is listed as N/A, indicating a leveraged position relative to shareholder equity. The current ratio stands at 1.75, which suggests the company possesses adequate short-term liquid assets to cover its current liabilities, providing a buffer against immediate liquidity crunches. Furthermore, the return on equity is -326.0% and the return on assets is -8.7%, metrics that reveal management has struggled to generate positive returns on the capital invested by shareholders and utilized in its asset base over the measured period.
Valuation Assessment
The valuation metrics for Cardlytics, Inc. show a trailing P/E ratio of N/A and a forward P/E of -2.45, implying that the market is pricing in continued negative earnings rather than a multiple of current profitability. The price-to-book ratio is -7.83, indicating that the stock trades at a significant discount relative to its book value, a common characteristic for companies with substantial accumulated losses or intangible assets not fully reflected on the balance sheet. Alternative valuation metrics such as a price-to-sales ratio of 0.22 and an EV/EBITDA of -9.95 suggest that the market values the company based on a very small fraction of its sales revenue, reflecting skepticism regarding its ability to convert revenue into sustainable cash flows. Regarding trading range, the stock has a 52-week high of $3.28 and a 52-week low of $0.66, meaning the current trading price sits within this historical volatility band, though the exact current price is not provided in the facts, the valuation multiples confirm a deep discount from the highs. The beta value of 1.09 indicates that the stock's price volatility is slightly higher than the broader market, suggesting that the stock will likely move more aggressively than the S&P 500 during periods of market turbulence.
Growth & Income
Revenue growth for the year-over-year period stands at -24.2%, while earnings growth is N/A due to the reported net loss. The absence of positive earnings growth compared to the contracting revenue indicates that the company is facing simultaneous challenges in both top-line sales performance and operational cost management, leading to a contraction in overall profitability. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the firm retains all its earnings, or in this case, absorbs all its losses, to fund operations or debt reduction rather than distributing income to shareholders. This non-dividend profile forces investors to rely entirely on capital appreciation or operational turnaround for returns, as there is no income component to the total return. Overall, the growth and income profile for Cardlytics, Inc. is characterized by negative revenue momentum, a lack of dividend income, and a reliance on existing cash reserves to navigate a period of financial contraction.